Quantbot Technologies LP Gilead Sciences, Inc. Transaction History

Quantbot Technologies LP

$2.36 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$63.15 - $72.88 $128,510 - $148,310	2,035 Added 25.99%	9,864 $676,000
Q1 2024 May 06, 2024	BUY	$71.58 - $87.29 $560,399 - $683,393	7,829 New	7,829 $573,000
Q3 2023 Nov 07, 2023	BUY	$73.94 - $80.67 $87,027 - $94,948	1,177 New	1,177 $88,000
Q2 2022 Aug 09, 2022	BUY	$57.72 - $65.01 $14,025 - $15,797	243 Added 2.76%	9,037 $558,000
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $137,965 - $172,885	2,382 Added 37.15%	8,794 $522,000
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $750,791 - $852,162	-11,572 Reduced 64.35%	6,412 $465,000
Q3 2021 Nov 09, 2021	SELL	$67.69 - $73.03 $89,621 - $96,691	-1,324 Reduced 6.86%	17,984 $1.26 Million
Q2 2021 Aug 12, 2021	BUY	$63.47 - $69.35 $1.23 Million - $1.34 Million	19,308 New	19,308 $1.33 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $7.32 Million - $8.35 Million	-121,951 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $6.62 Million - $7.55 Million	116,892 Added 2310.58%	121,951 $7.1 Million
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $314,163 - $395,006	5,059 New	5,059 $319,000
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $45,284 - $52,584	-626 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $1.42 Million - $1.82 Million	-22,731 Reduced 97.32%	626 $46,000
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $1.72 Million - $1.9 Million	-27,960 Reduced 54.48%	23,357 $1.52 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $412,753 - $455,607	6,603 Added 14.77%	51,317 $3.25 Million
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $7.23 Million - $8.11 Million	-116,858 Reduced 72.33%	44,714 $3.02 Million
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $5.86 Million - $6.57 Million	93,750 Added 138.23%	161,572 $10.5 Million
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $1.17 Million - $1.53 Million	19,381 Added 40.01%	67,822 $4.24 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $239,714 - $265,407	-3,363 Reduced 6.49%	48,441 $3.74 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $2 Million - $2.33 Million	30,791 Added 146.53%	51,804 $3.67 Million
Q1 2018 May 11, 2018	BUY	$72.84 - $88.8 $329,673 - $401,908	4,526 Added 27.45%	21,013 $1.58 Million
Q4 2017 Feb 12, 2018	SELL	$71.15 - $83.52 $485,243 - $569,606	-6,820 Reduced 29.26%	16,487 $1.18 Million
Q3 2017 Nov 07, 2017	BUY	$72.11 - $85.47 $1.68 Million - $1.99 Million	23,307	23,307 $1.89 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.

Account